1
2
3
4
5
6
7
8
9
10
11
12
13 | On December 15, 2023, Licensing Program Analyst (LPA) Komal Charitra conducted an unannounced complaint visit to deliver the findings for the above allegations. LPA met with Executive Director, Ella Frick and explained the purpose of the visit.
Regarding the allegation, staff did not administer resident's medication as prescribed, according to the reporting party, Resident 1 (R1) should be receiving 200mgs of a prescribed medication daily. In addition, reporting party indicated that the prescribed medication comes in 100mg tablets so R1 should be receiving two tablets a day in the morning, the facility’s instructions were to provide one tablet a day.
During the visit, LPA interviewed staff, observed R1's medications, reviewed R1's physician's orders and MAR. Based on documentation reviewed, LPA observed a discrepancy between the physician's order, the MAR system being used by the facility, and the prescription bottle that was given by the pharmacy. According to the physician's order and the MAR system, R1 was prescribed 200mgs tablet of Lamotrigine and instructions were to take 1 tablet by mouth daily per physician's order. However, based on observations, R1's Lamotrigine prescription bottle contained 100mg tablets and instructions were to take 2 tablets (200mg) by mouth daily. The facility observed the discrepancy, however failed to contact the physician and/or the pharmacy for clarification.
On 11/30/23, LPA conducted a complaint visit and observed R1's Lamotrigine prescription bottle. R1 started his/her prescription bottle of Lamotrigine (100mg/quantity 180 tablets) on 8/23/2023. During the visit on 11/30/2023, LPA observed 8 tablets in the bottle. Based on MAR review, R1 has never refused his/her Lamotrigine prescription. In addition, based on staff interviewed, R1 should have started a new prescription bottle on 11/22/2023. Furthermore, based on staff interviewed, it was observed that a staff member accidentally gave R1 one tablet of Lamotrigine, however caught the issue and provided R1 another tablet. (CONT. TO 9099C) |